Chicago, Current Research, Dr. Wesevich, Drug, Health Disparities, Minority/Underserved, Rare, University of Chicago
Testing a Low-Dose Anti-inflammatory Drug (Tocilizumab) for Acute Chest Syndrome in Sickle Cell Disease Principal Investigator: Dr. Austin Wesevich Condition: acute chest syndrome in sickle cell disease Research Description: Sickle cell disease (SCD) is a rare...
